A 55-year-old man presented with a two-month history of tumour formation between the eyes and in the right nostril. In addition he had massive cervical lymphadenopathy and extensive infiltration of the skin of the face and trunk. Biopsy specimens were Accepted for publication 8 December 1982 first interpreted as undifferentiated carcinoma and subsequently as diffuse histiocytic lymphoma.1 The blood count was normal and a bone marrow aspirate was not done. The forehead lesion was irradiated and cyclophosphamide and vincristine were given. Two months after presentation (seven months from first symptoms) the white cell and platelet counts had fallen; monoblasts and promonocytes were present in the peripheral blood (Fig.
SUMMARY Four patients in whom a diagnosis of acute monocytic leukaemia (M5) was subsequently made presented with extramedullary disease clinically resembling lymphoma. In all patients histological sections were initially misinterpreted as showing malignant lymphoma or anaplastic carcinoma. The diagnosis of M5 leukaemia was subsequently made on the basis of morphological and cytochemical studies of peripheral blood and bone marrow. The histological diagnosis of the soft tissue lesions of M5 leukaemia (monocytic sarcoma) is difficult, although features such as abundant cytoplasm and the presence of some reniform nuclei are helpful. If there is no peripheral blood or bone marrow involvement and only fixed paraffin-embedded tissues are available, demonstration of lysozyme by an immunoperoxidase technique may confirm the diagnosis but results are not invariably positive. An early diagnosis of M5 leukaemia has therapeutic implications since the disease evolves through a progressive leukaemia phase and systemic therapy is essential. A 55-year-old man presented with a two-month history of tumour formation between the eyes and in the right nostril. In addition he had massive cervical lymphadenopathy and extensive infiltration of the skin of the face and trunk. Biopsy specimens were Accepted for publication 8 December 1982 first interpreted as undifferentiated carcinoma and subsequently as diffuse histiocytic lymphoma.1 The blood count was normal and a bone marrow aspirate was not done. The forehead lesion was irradiated and cyclophosphamide and vincristine were given. Two months after presentation (seven months from first symptoms) the white cell and platelet counts had fallen; monoblasts and promonocytes were present in the peripheral blood (Fig. 1 Acute monoblastic leukaemia may present with no extramedullary involvement, with both medullary and extramedullary disease, or with extramedullary tumour with the later evolution to leukaemia. Correct diagnosis may be particularly important in the third group. It is not known whether in such patients the origin of the leukaemic clone is in the bone marrow with early seeding to extramedullary sites, or whether its origin is extramedullary with haematogenous spread to bone marrrow and other sites. If the latter is the case then it might be possible to harvest and cryopreserve bone marrow prior to systemic chemotherapy in those patients who have no evidence of marrow involvement at presentation. In either case the recognition of the cell line involved indicates the need for intensive systemic therapy rather than local therapy (eg radiotherapy) for successful treatment of this disease. Correct diagnosis is also important to avoid misinterpretation of acute monocytic leukaemia as a therapyrelated leukaemia following successful treatment of a lymphoma. It may be justifiable to regard a soft tissue monocytic sarcoma as a "true histiocytic lymphoma" but it should then be recognised that a subsequent acute monocytic leukaemia is another phase of the same malignant proliferation and not a second malignancy. This tumour should not be confused with the larger group of "histiocytic" lymphomas of Rappaport's classification.' The majority of such tumours can now be identified as being of T or B lymphocyte origin, although a significant proportion of the non-B, non-T (null) lymphomas are of true histiocytic origin.7 Since the monocyte and the histiocyte belong to the same cell line a monocytic sarcoma and a true histiocytic lymphoma may be regarded as variants of the same tumour type. The former designation emphasises that this tumour is part of the spectrum of acute monocytic leukaemia whereas the latter name suggests histological similarities to lymphomas of true lymphoid origin. The relation to acute monocytic leukaemia is further emphasised by the natural history of the disease which almost always terminates in frank monocytic leukaemia.
